Highlights and Quick Summary
- EBIT Growth for the quarter ending September 30, 2022 was 0.19 (a -293.17% decrease compared to previous quarter)
- Year-over-year quarterly EBIT Growth decreased by -105.57%
- Annual EBIT Growth for 2021 was -0.79 (a -651.33% decrease from previous year)
- Annual EBIT Growth for 2020 was 0.14 (a -45.17% decrease from previous year)
- Annual EBIT Growth for 2019 was 0.26 (a 41.6% increase from previous year)
- Twelve month EBIT Growth ending September 30, 2022 was -0.52 (a -49.88% decrease compared to previous quarter)
- Twelve month trailing EBIT Growth decreased by -34.3% year-over-year
Trailing EBIT Growth for the last four month:
| 30 Sep '22 | 30 Jun '22 | 31 Mar '22 | 31 Dec '21 |
|---|---|---|---|
| -0.52 | -1.03 | -1.48 | -0.79 |
Visit stockrow.com/BDSX
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical EBIT Growth of Biodesix, Inc.
Most recent EBIT Growthof BDSX including historical data for past 10 years.Interactive Chart of EBIT Growth of Biodesix, Inc.
Biodesix, Inc. EBIT Growth for the past 10 Years (both Annual and Quarterly)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | – | 0.19 | -0.1 | -1.59 | – |
| 2021 | -3.4 | -1.1 | -0.88 | 0.34 | -0.79 |
| 2020 | – | – | – | 0.71 | 0.14 |
| 2019 | – | – | – | – | 0.26 |
| 2018 | – | – | – | – | 0.18 |
Business Profile of Biodesix, Inc.
Sector: Healthcare
Industry: Diagnostics & Research